FDA Clearance Tracker · K261466
Alegria Flash MPO; Alegria Flash PR3; Alegria Flash GBM
Last checked: Nov 20, 2026Latest source record: Aug 21, 2026 (this decision)Source: openFDAMethods & limitations
Decided
Aug 21, 2026
Substantially Equivalent
Time to decision
109 days
Received May 4, 2026. Calendar days, including time FDA spent waiting on the applicant.
Pathway
510(k)
Traditional
Device class
Class II
The decision
- FDA number
- K261466
- Device name
- Alegria Flash MPO; Alegria Flash PR3; Alegria Flash GBM
- Applicant
- Zeus Scientific
- Applicant location
- Branchburg, NJ
- Received
- May 4, 2026
- Decided
- Aug 21, 2026
- Decision
- Substantially Equivalent
- Submission type
- Traditional
Device type
- Device class
- Class II
- Regulation
- 21 CFR 866.5660
- Specialty
- Laboratory Medicine & Pathology
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- It is not the first decision under product code MOB. The earliest in FDA's data is K943630, decided Mar 6, 1995.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
- FDA database record for K261466
- 510(k) summary (PDF) · FDA posts these some weeks after the decision, so a recent one may not open yet.
The predicate devices this clearance relied on are named in the summary document. We do not extract them yet.
Other decisions for Zeus Scientific
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K250814 · Decided May 8, 2026 · 417 days after receipt
Device type: Anti-Ss-A 52 Autoantibodies (OBE) · Laboratory Medicine & Pathology
- Alegria Flash CTD Screen510(k)
K250666 · Decided Oct 22, 2025 · 231 days after receipt
Device type: Extractable Antinuclear Antibody, Antigen And Control (LLL) · Laboratory Medicine & Pathology
- Alegria Flash ENA Screen510(k)
K250408 · Decided Sep 19, 2025 · 218 days after receipt
Device type: Extractable Antinuclear Antibody, Antigen And Control (LLL) · Laboratory Medicine & Pathology
5 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.